Mr Rob Carroll

KANDO id: 15791

Bio

Managing Director of Catapult having joined the firm in October 1999.Previously with 3i plc in Leicester and London. Focuses on origination activities, investor relations as well as investments. Specific interest in the healthcare and environmental areas. Recent investments include R5 pharmaceuticals, Critical Pharmaceuticals and Key Technologies. He is a member of the BVCA Ventures Committee and a Non Executive Director of Charles Lawrence Group plc in Newark. Honours graduate in Pharmacy from Kings College London and a registered Pharmacist. MBA from Bradford University Management School.

Education